Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gozo, MC"'
Publikováno v:
Oncotarget, vol 7, iss 42
Gozo, MC; Jia, D; Aspuria, P-J; Cheon, D-J; Miura, N; Walts, AE; et al.(2016). FOXC2 augments tumor propagation and metastasis in osteosarcoma. ONCOTARGET, 7(42), 68792-68802. doi: 10.18632/oncotarget.11990. UCLA: Retrieved from: http://www.escholarship.org/uc/item/97b3d741
Gozo, MC; Jia, D; Aspuria, P-J; Cheon, D-J; Miura, N; Walts, AE; et al.(2016). FOXC2 augments tumor propagation and metastasis in osteosarcoma. ONCOTARGET, 7(42), 68792-68802. doi: 10.18632/oncotarget.11990. UCLA: Retrieved from: http://www.escholarship.org/uc/item/97b3d741
Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e5e9a625c05eba4aee41cb61472264cf
https://escholarship.org/uc/item/97b3d741
https://escholarship.org/uc/item/97b3d741
Autor:
Recouvreux MS; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Miao J; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA., Gozo MC; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Wu J; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA., Walts AE; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Karlan BY; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90095, USA., Orsulic S; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90095, USA.; Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, CA 90095, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Oct 04; Vol. 14 (19). Date of Electronic Publication: 2022 Oct 04.
Autor:
Aspuria PJ; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Cheon DJ; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Gozo MC; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Beach JA; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Recouvreux MS; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA., Walts AE; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Karlan BY; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, 90095, USA; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA., Orsulic S; Women's Cancer Program, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, 90095, USA; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. Electronic address: sorsulic@mednet.ucla.edu.
Publikováno v:
Experimental cell research [Exp Cell Res] 2020 Aug 01; Vol. 393 (1), pp. 112039. Date of Electronic Publication: 2020 May 04.
Autor:
Wang C; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Park J; Department of Diagnostic Radiology, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Ouyang C; Center for Informatics, Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA., Longmate JA; Division of Biostatistics, Beckman Research Institute of the City of Hope, Duarte, California, USA., Tajon M; Clinical Trial Office, City of Hope National Medical Center, Duarte, California, USA., Chao J; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Lim D; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Sandhu J; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Yin HH; Department of Pathology, City of Hope National Medical Center, Duarte, Calilfornia, USA., Pillai R; Department of Pathology, City of Hope National Medical Center, Duarte, Calilfornia, USA., Gozo MC; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, California, USA., Avalos C; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, California, USA., Egelston CA; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, California, USA., Lee PP; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, California, USA., Fakih M; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Publikováno v:
The oncologist [Oncologist] 2020 May; Vol. 25 (5), pp. 382-e776. Date of Electronic Publication: 2019 Dec 19.
Autor:
Fakih M; Department of Medical Oncology and Therapeutics Research, and., Ouyang C; Center for Informatics, City of Hope National Medical Center, Duarte, California, USA.; Department of Computational and Quantitative Medicine., Wang C; Department of Medical Oncology and Therapeutics Research, and., Tu TY; Department of Immuno-Oncology, and., Gozo MC; Department of Immuno-Oncology, and., Cho M; Department of Medical Oncology and Therapeutics Research, and., Sy M; Department of Medical Oncology and Therapeutics Research, and., Longmate JA; Department of Computational and Quantitative Medicine.; Division of Biostatistics, Beckman Research Institute of the City of Hope, Duarte, California, USA., Lee PP; Department of Immuno-Oncology, and.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2019 Oct 01; Vol. 129 (10), pp. 4464-4476.
Autor:
Gozo MC; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Graduate Program in Biomedical Science and Translational Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Jia D; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Aspuria PJ; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Cheon DJ; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Miura N; Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan., Walts AE; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2016 Oct 18; Vol. 7 (42), pp. 68792-68802.
Autor:
Gozo MC; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA., Aspuria PJ, Cheon DJ, Walts AE, Berel D, Miura N, Karlan BY, Orsulic S
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2013 Aug; Vol. 20 (8), pp. 1031-42. Date of Electronic Publication: 2013 May 03.